CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

Core Viewpoint - CDT Equity Inc. acknowledges the filing of a U.S. provisional patent application by Sarborg Limited for its AI Signature Agent, viewing it as a significant step in enhancing Sarborg's intellectual property position and supporting its long-term growth potential [1][3]. Group 1: Patent Filing Details - Sarborg filed a provisional patent application with the United States Patent and Trademark Office on February 12, 2026, assigned United States Patent Application No. 63/981,801 [2]. - The application pertains to Sarborg's Signature Agent architecture and its methodology for encoding and analyzing biological, chemical, and industrial signatures to produce intelligence-driven outputs [2]. Group 2: Company Perspective - As a 20% shareholder, CDT views the patent filing as a crucial milestone in the development and protection of Sarborg's proprietary technology [3]. - The advancement of Sarborg's intellectual property is believed to support the scalability of its Signature Agent across various sectors, enhancing its long-term growth profile [3]. Group 3: Company Overview - CDT Equity Inc. is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships [4]. - The company aims to create shareholder value through licensing, strategic mergers and acquisitions, and positioning itself as a platform for transformative innovation [4].